|
1.
|
Rose PG, Bundy BN, Watkins EB, Thigpen JT,
Deppe G, Maiman MA, Clarke-Pearson DL and Insalaco S: Concurrent
cisplatin-based radiotherapy and chemotherapy for locally advanced
cervical cancer. N Engl J Med. 340:1144–1153. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Morris M, Eifel PJ, Lu J, Grigsby PW,
Levenback C, Stevens RE, Rotman M, Gershenson DM and Mutch DG:
Pelvic radiation with concurrent chemotherapy compared with pelvic
and paraaortic radiation for high-risk cervical cancer. N Engl J
Med. 340:1137–1143. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Whitney CW, Sause W, Bundy BN, Malfetano
JH, Hannigan EV, Fowler WC Jr, Clarke-Pearson DL and Liao SY:
Randomized comparison of fluorouracil plus cisplatin versus
hydroxyurea as an adjunct to radiation therapy in stage IIB–IVA
carcinoma of the cervix with negative para-aortic lymph nodes: a
Gynecologic Oncology Group and Southwest Oncology Group study. J
Clin Oncol. 17:1339–1348. 1999.PubMed/NCBI
|
|
4.
|
Sardi JE, Giaroli A, Sananes C, Ferreira
M, Soderini A, Bermudez A, Snaidas L, Vighi S, Gomez Rueda N and di
Paola G: Long-term follow-up of the first randomized trial using
neoadjuvant chemotherapy in stage Ib squamous carcinoma of the
cervix: the final results. Gynecol Oncol. 67:61–69. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Benedetti-Panici P, Greggi S, Colombo A,
Amoroso M, Smaniotto D, Giannarelli D, Amunni G, Raspagliesi F,
Zola P, Mangioni C and Landoni F: Neoadjuvant chemotherapy and
radical surgery versus exclusive radiotherapy in locally advanced
squamous cell cervical cancer: results from the Italian
multi-center randomized study. J Clin Oncol. 20:179–188. 2002.
View Article : Google Scholar
|
|
6.
|
Neoadjuvant Chemotherapy for Locally
Advanced Cervical Cancer Meta-analysis Collaboration: Neoadjuvant
chemotherapy for locally advanced cervical cancer: a systematic
review and meta-analysis of individual patient data from 21
randomised trials. Eur J Cancer. 39:2470–2486. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Chang TC, Lai CH, Hong JH, Hsueh S, Huang
KG, Chou HH, Tseng CJ, Tsai CS, Chang JT, Lin CT, Chang HH, Chao
PJ, Ng KK, Tang SG and Soong YK: Randomized trial of neoadjuvant
cisplatin, vincristine, bleomycin, and radical hysterectomy versus
radiation therapy for bulky stage IB and IIA cervical cancer. J
Clin Oncol. 18:1740–1747. 2000.
|
|
8.
|
Kumar L, Kaushal R, Nandy M, Biswal BM,
Kumar S, Kriplani A, Singh R, Rath GK and Kochupillai V:
Chemotherapy followed by radiotherapy versus radiotherapy alone in
locally advanced cervical cancer: a randomized study. Gynecol
Oncol. 54:307–315. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Sundfor K, Trope CG, Hogberg T, Onsrud M,
Koern J, Simonsen E, Bertelsen K and Westberg R: Radiotherapy and
neoadjuvant chemotherapy for cervical carcinoma. A randomized
multicenter study of sequential cisplatin and 5-fluorouracil and
radiotherapy in advanced cervical carcinoma stage 3B and 4A.
Cancer. 77:2371–2378. 1996. View Article : Google Scholar
|
|
10.
|
Souhami L, Gil RA, Allan SE, Canary PC,
Araujo CM, Pinto LH and Silveira TR: A randomized trial of
chemotherapy followed by pelvic radiation therapy in stage IIIB
carcinoma of the cervix. J Clin Oncol. 9:970–977. 1991.PubMed/NCBI
|
|
11.
|
Tattersall MH, Lorvidhaya V, Vootiprux V,
et al: Randomized trial of epirubicin and cisplatin chemotherapy
followed by pelvic radiation in locally advanced cervical cancer.
Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology
Association. J Clin Oncol. 13:444–451. 1995.
|
|
12.
|
Park SY, Kim BG, Kim JH, Lee JH, Lee ED,
Lee KH, Park KB, Lee BH and Kim KH: Phase I/II study of neoadjuvant
intraarterial chemotherapy with mitomycin-C, vincristine, and
cisplatin in patients with stage IIb bulky cervical carcinoma.
Cancer. 76:814–823. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Scarabelli C, Zarrelli A, Gallo A and
Visentin MC: Multimodal treatment with neoadjuvant intraarterial
chemotherapy and radical surgery in patients with stage IIIB–IVA
cervical cancer. A preliminary study. Cancer. 76:1019–1026.
1995.
|
|
14.
|
Sugiyama T, Nishida T, Hasuo Y, Fujiyoshi
K and Yakushiji M: Neoadjuvant intraarterial chemotherapy followed
by radical hysterectomy and/or radiotherapy for locally advanced
cervical cancer. Gynecol Oncol. 69:130–136. 1998. View Article : Google Scholar
|
|
15.
|
Yamakawa Y, Fujimura M, Hidaka T, Hori S
and Saito S: Neoadjuvant intraarterial infusion chemotherapy in
patients with stage IB2–IIIB cervical cancer. Gynecol Oncol.
77:264–270. 2000.
|
|
16.
|
Piver MS, Rutledge F and Smith JP: Five
classes of extended hysterectomy for women with cervical cancer.
Obstet Gynecol. 44:265–272. 1974.PubMed/NCBI
|
|
17.
|
Bierman HR, Byron RL Jr, Miller ER and
Shimkin MB: Effects of intra-arterial administration of nitrogen
mustard. Am J Med. 8:5351950. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Cromer JK, Bateman JC, Berry GN, Kennelly
JM, Klopp CT and Platt LI: Use of intra-arterial nitrogen mustard
therapy in the treatment of cervical and vaginal cancer. Am J
Obstet Gynecol. 63:538–548. 1952.PubMed/NCBI
|
|
19.
|
Toita T, Moromizato H, Ogawa K, Kakinohana
Y, Maehama T, Kanazawa K and Murayama S: Concurrent
chemoradiotherapy using high-dose-rate intracavitary brachytherapy
for uterine cervical cancer. Gynecol Oncol. 96:665–670. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Umesaki N, Fujii T, Nishimura R, Tanaka T,
Nishida M, Fushiki H, Takizawa K, Yamamoto K, Hasegawa K and Izumi
R: Phase II study of irinotecan combined with mitomycin-C for
advanced or recurrent squamous cell carcinoma of the uterine
cervix: the JGOG study. Gynecol Oncol. 95:127–132. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Dimopoulos MA, Papadimitriou CA, Sarris K,
Aravantinos G, Kalofonos C, Gika D, Gourgoulis GM, Efstathiou E,
Skarlos D and Bafaloukos D: Combination of ifosfamide, paclitaxel,
and cisplatin for the treatment of metastatic and recurrent
carcinoma of the uterine cervix: a phase II study of the Hellenic
Cooperative Oncology Group. Gynecol Oncol. 85:476–482. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Papadimitriou CA, Sarris K, Moulopoulos
LA, Fountzilas G, Anagnostopoulos A, Voulgaris Z, Gika D,
Giannakoulis N, Diakomanolis E and Dimopoulos MA: Phase II trial of
paclitaxel and cisplatin in metastatic and recurrent carcinoma of
the uterine cervix. J Clin Oncol. 17:761–766. 1999.PubMed/NCBI
|
|
23.
|
Iwasaka T, Fukuda K, Hara K, Yokoyama M,
Nakao Y, Uchiyama M and Sugimori H: Neoadjuvant chemotherapy with
mitomycin C, etoposide, and cisplatin for adenocarcinoma of the
cervix. Gynecol Oncol. 70:236–240. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Lissoni A, Gabriele A, Gorga G, Tumolo S,
Landoni F, Mangioni C and Sessa C: Cisplatin-, epirubicin- and
paclitaxel-containing chemotherapy in uterine adenocarcinoma. Ann
Oncol. 8:969–972. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Benedetti-Panici P, Greggi S, Scambia G,
Salerno MG, Amoroso M, Maneschi F, Cutillo G, Caruso A, Capelli A
and Mancuso S: Locally advanced cervical adenocarcinoma: is there a
place for chemo-surgical treatment? Gynecol Oncol. 61:44–49. 1996.
View Article : Google Scholar : PubMed/NCBI
|
